← Eichor
Condition: Attr Amyloidosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Attr Amyloidosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Exercise Training in Transthyretin Cardiac Amyloidosis
NA · 1 location(s) · Brigham and Women's Hospital · NCT05797857Exercise in Hereditary ATTR (ATTRv) Amyloidosis
NA · 1 location(s) · University of Maia · NCT07033715ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Phase N/A · 40 location(s) · Alnylam Pharmaceuticals · NCT04561518Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Phase 4 · 16 location(s) · Alexion Pharmaceuticals, Inc. · NCT07306949Comprehensive Program for Hereditary Transthyretin Amyloidosis
Phase N/A · 1 location(s) · Hospital de Alta Complejidad en Red · NCT07213297Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase N/A · 1 location(s) · Yale University · NCT07398950Description of a Retrospective Cohort of Patients With Transthyretin Cardiac Amyloidosis (ATTR-CA) in Internal Medicine
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06907836FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
Phase N/A · 1 location(s) · xCures · NCT06539169To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transth
Phase 4 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT06940336PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY
NA · 1 location(s) · Richmond Research Institute · NCT05098665Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
Phase 2 · 1 location(s) · Oregon Health and Science University · NCT05758493Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
NA · 1 location(s) · Massachusetts General Hospital · NCT05577819Essen Amyloidosis Registry
Phase N/A · 1 location(s) · University Hospital, Essen · NCT06887283A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Phase N/A · 26 location(s) · Akcea Therapeutics · NCT04850105CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in Peop
Phase 3 · 292 location(s) · Novo Nordisk A/S · NCT07207811A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis
Phase 1 · 1 location(s) · University of Tennessee Graduate School of Medicine · NCT05951816A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT I
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07448623TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidos
Phase 3 · 41 location(s) · Alnylam Pharmaceuticals · NCT07223203ATTR Amyloid Cardiomyopathy: Characterization of Extracellular Vesicles as Potential Disease Stratifiers and Prognostic
Phase N/A · 1 location(s) · University of Sao Paulo General Hospital · NCT07314268Thailand ATTR-CM Registry
Phase N/A · 8 location(s) · Mahidol University · NCT06338696TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3 · 240 location(s) · Alnylam Pharmaceuticals · NCT07052903A Phase 3 Study of NTLA-2001 in ATTRv-PN
Phase 3 · 14 location(s) · Intellia Therapeutics · NCT06672237MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · 132 location(s) · Intellia Therapeutics · NCT06128629A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability,
Phase 1/Phase 2 · 3 location(s) · YolTech Therapeutics Co., Ltd · NCT06539208Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients
NA · 1 location(s) · Assistance Publique Hopitaux De Marseille · NCT06845644The Italian Transthyretin Amyloidosis Web-Network
Phase N/A · 30 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT05444920Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients Wit
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT07196839Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Phase 1/Phase 2 · 1 location(s) · Steen Hvitfeldt Poulsen · NCT06318260Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
NA · 1 location(s) · Dominik Benz · NCT07112066Efficacy and Safety of Intravenous YOLT-201 for Transthyretin Amyloidosis Cardiomyopathy
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06082050
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.